As explained in the introduction, skeletal growth is a mechanical force, but it is also subjected to a large variety of hormones [
80]. Some of these directly affect growth (like growth hormone produced by the pituary gland and IGF-1 produced by the liver), and it appears that e.g
. integrated growth hormone levels are substantially and significantly higher in AIS patients under 12, but not different at higher age [
80,
81]. Other hormones are related to brain function (growth hormone releasing hormone (GHRH) produced by the hypothalamus) or nutrition (insulin produced by the pancreas; hunger hormones ghrelin and leptin, produced by the stomach and fat cells, respectively) [
82]. Nutrition presumably determines the growth and strengthening of muscles, as suggested by the higher incidence of scoliosis in patients with eating disorders [
58]. Melatonin (produced by the pineal gland) is widely investigated in the context of scoliosis, because experimental rat studies show that a depletion is related to the development of scoliosis [
78] and that the volume of the pineal gland is smaller in AIS patients than in healthy controls [
83]. Nevertheless, its mechanism remains obscure [
84‐
86]. An interesting cue may be that a high concentration of melatonin receptors is found in the cerebellum [
87], the small brain that governs motor control and balance [
88] and thus may underlie muscular activity. Another interesting hormone is relaxin, a hormone produced by the prostate in men and in breasts and ovary in women [
89]. Relaxin appears to interfere with connective tissues, presumably as a competitor of SLRPs like decorin that function as anchor points for cross-links between collagen fibrils [
79]. Considering the late menarche in many girls developing AIS [
6], it is also noticeable that relaxin production rises after ovulation and declines towards menstruation. A late first menstruation delays the production of relaxin and thereby may increase collagenous cross-linking in ligaments and reduce its growth potential. Estrogen, as a last example, increases collagen turnover and decreases the stiffness of tendons and ligaments by inhibiting lysyl oxidase and decreasing cross-linking [
90,
91]. A lack of estrogen, as a result of late menarche, thus enhances cross-linking and reduces growth potential of tendons and ligaments. Interestingly, levels of oestradiol are indeed reported to be lower in girls with AIS than in age-matched controls [
92,
93]. Overall, a large variety of hormones interacts with tissues, functions and each other in many different ways [
94]. An exploration of these from the perspective of differential growth is of great interest and a topic for future research.